Description
BSE announces the upcoming listing and admission to trading of equity shares of Accretion Nutraveda Limited on the SME segment.
Summary
BSE has informed trading members that equity shares of Accretion Nutraveda Limited will be listed and admitted to dealings on the Exchange’s SME segment in due course. The company has been assigned scrip code 544694, symbol ANL, and ISIN INE1KVQ01019. The exact listing date and security details will be communicated through a separate notice.
Key Points
- Company Name: Accretion Nutraveda Limited
- Scrip Code: 544694
- Symbol: ANL
- ISIN: INE1KVQ01019
- Segment: SME
- Listing date to be announced separately
Regulatory Changes
No regulatory changes announced in this circular.
Compliance Requirements
Trading members should note the scrip details for Accretion Nutraveda Limited and await further notice regarding the listing date and security details.
Important Dates
- Notice Date: February 3, 2026
- Listing Date: To be announced through separate notice
Impact Assessment
This is a routine listing announcement for the SME segment with minimal immediate market impact. Trading members need to update their systems with the new scrip information. The actual listing date and security details will be provided in a subsequent circular, at which point trading can commence.
Impact Justification
Routine listing announcement for a single SME company with no immediate trading date specified